The device failures could lead to increased or decreased values of CO2, which could be fatal, according to a U.S. Food and Drug Administration news release. Additionally, physicians may make clinical decisions based off incorrect displayed values, potentially causing permanent impairment or life-threatening changes.
Currently there have been no reports of injury or death associated with the recalled device, according to the news release.
More articles on recalls:
American Health Packaging recalls oxcarbazepine, ibuprofren for mislabeled packages
Baxter initiates worldwide saline solution recall
Hospira recalls Encore Infusion pumps
Register to Attend Webinar
Presenters:
Joel Ray, COL, USAF, NC, MSN, RN, NEA-BC, Laudio and StaffGarden by Ascend Learning|Larissa Africa, MBA, RN, CENP, FAONL, FAAN, StaffGarden by Ascend Learning|Alicia Potolsky, DNP, RN, NE-BC, DipACLM, El Camino Health|Julie Balluck, DNP, RN, NEA-BC, Texas Health Resources
Next Up in Supply Chain
-
Ville Platte, La.-based Mercy Regional Medical Center has signed a prime vendor agreement with Medline for medical-surgical products and distribution…
-
Three group purchasing organizations served as the primary GPOs for more than 80% of U.S. hospitals in 2024, according to…
-
The federal government has invested $15.97 million in a project designed to establish a fully domestic pharmaceutical supply chain in…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
